Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis

被引：0
|
作者：
Davis, J. C. [1 ]
van der Heijde, D. [2 ]
Braun, D. [3 ]
Dougados, M.
Clegg, D. O. [4 ]
Kivits, A. [5 ]
Fleischmann, R. [6 ]
Inmann, R. [7 ]
Ni, L. [8 ]
Lin, S. [8 ]
Tsuji, W. [8 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Hosp Maastricht, Maastricht, Netherlands
[3] Hosp Cochin, Paris, France
[4] Univ Utah, Ctr Med, Salt Lake City, UT USA
[5] Altoona Ctr Clin Res, Duncansville, TX USA
[6] Univ Texas SW Med Ctr Dallas, Dallas, TX USA
[7] Toronto Western Hosp, Toronto, ON, Canada
[8] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：393 / 394
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis
    Davis, J. C., Jr.
    van der Heijde, D. M.
    Braun, J.
    Dougados, M.
    Clegg, D. O.
    Kivitz, A. J.
    Fleischmann, R. M.
    Inman, R. D.
    Ni, L.
    Lin, S-L
    Tsuji, W. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) : 346 - 352
  • [2] Safety and efficacy of etanercept therapy in ankylosing spondylitis patients undergoing phacoemulsification surgery
    Kemeny-Beke, Adam
    Szekanecz, Zoltan
    Szanto, Sandor
    Bodnar, Nora
    Modis, Laszlo, Jr.
    Gesztelyi, Rudolf
    Zsuga, Judit
    Szodoray, Peter
    Berta, Andras
    RHEUMATOLOGY, 2010, 49 (11) : 2220 - 2221
  • [3] Sustained efficacy and safety of patients with ankylosing spondylitis treated with etanercept: Outcomes at 148-160 weeks of long term therapy.
    Sieper, Joachim
    Dijkmans, Benjamin A. C.
    van der Linden, Sjef
    Mola, Emilio Martin
    Sibilia, Jean
    Leirisalo-Repo, Majatta
    Nab, Henk W.
    Chang, David
    Freundlich, Bruce
    MacPeek, David
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S473 - S473
  • [4] The efficacy of etanercept in ankylosing spondylitis
    Christopher T. Ritchlin
    Current Rheumatology Reports, 2004, 6 (2) : 95 - 95
  • [5] The efficacy of etanercept in ankylosing spondylitis
    Christopher T. Ritchlin
    Current Rheumatology Reports, 2004, 6 (2) : 95 - 96
  • [6] Sustained efficacy of etanercept in ankylosing spondylitis for up to 2 years
    Davis, JC
    Van der Heijde, DM
    Braun, J
    Dougados, M
    Cush, J
    Clegg, DO
    Inman, RD
    Kivitz, A
    Zhou, L
    Tsuji, W
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 336 - 336
  • [7] EFFICACY OF ETANERCEPT THERAPY WITH AN EVERY OTHER WEEK REGIMEN IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    De Stefano, R.
    Frati, E.
    Menza, L.
    Galeazzi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 250 - 250
  • [8] Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
    Miguel Senabre-Gallego, Jose
    Santos-Ramirez, Carlos
    Santos-Soler, Gregorio
    Salas-Heredia, Esteban
    Sanchez-Barrioluengo, Mabel
    Barber, Xavier
    Rosas, Jose
    PATIENT PREFERENCE AND ADHERENCE, 2013, 7 : 961 - 972
  • [9] Observation of Clinical Efficacy of Etanercept and Infliximab in Patients with Ankylosing Spondylitis
    Zhang, Fengfei
    Sun, Qingzeng
    Qi, Yudong
    Shen, Yang
    Shi, Yingchun
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 : 426 - 427
  • [10] Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
    Brandt, J
    Listing, J
    Haibel, H
    Sörensen, H
    Schwebig, A
    Rudwaleit, M
    Sieper, J
    Braun, J
    RHEUMATOLOGY, 2005, 44 (03) : 342 - 348
12345